Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Impact of the Updated IPSS-Molecular Prognostic Scoring System for Myelodysplastic Syndrome in 10,283 Real World Samples

Grant Hogg, Qian Zeng, Heidi M Hoffman, Eric A. Severson, Li Cai, Wenjie Chen, Sabrina Gardner, Kimberly A Holden, Lax Iyer, Angela Leo Kenyon, Deborah Boles, Scott Parker, Stanley Letovsky, Henry Dong, Narasimhan Nagan, Shakti Ramkissoon, Marcia Eisenberg, Anjen Chenn, Taylor J Jensen

Blood (2022) 140 (Supplement 1): 9783–9784.

https://doi.org/10.1182/blood-2022-160424

Published: 2022

Journal Articles

Genomic Ancestry in B Cell Lymphoid Malignancies

Jay A Moore, Andrew M. Evens, DO,MMSc, Justin Newberg, PhD, Eric A. Severson, MD, PhD, MMSc, Jennifer Mills, PhD MSW, MPH, Jordan Carter, MD, Rahul Matnani, MD, Jo-Anne Vergilio, MD, Sally E Trabucco, PhD, Shridar Ganesan, MD, PhD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-137533

Published: 2020

Journal Articles

Acid-Based Decalcification Methods Compromise Genomic Profiling from DNA and RNA

Ian Duncan, Natalie Danziger, Daniel Duncan, MD, Amanda Hemmerich, MD, Claire Edgerly, MD, Richard Huang, MD, Jo-Anne Vergilio, MD, Julia A Elvin, MD PhD, Jie He, PhD, Nicholas Britt, Prasanth Reddy, MD, Pratheesh Sathyan, MD, Brian Alexander, MD, Jeffrey S. Ross, MD, Charlotte Brown, PhD, Shakti H. Ramkissoon, MD PhD, Eric A. Severson, MD, PhD, MMSc

Blood (2019) 134 (Supplement_1): 4659.

https://doi.org/10.1182/blood-2019-131362

Published: 2019

Journal Articles

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Lucas R. Massoth, MD, Yin P. Hung, MD, PhD, Judith A. Ferry, MD, Robert P. Hasserjian, MD, Abner Louissaint, Jr., MD PhD, Meagan Montesion, PhD, Ethan S. Sokol, PhD, Dean C. Pavlick, Nikunj Shah, Natalie Danziger, Jonathan Keith Killian, MD,PhD, Eric A. Severson, MD, PhD, MMSc, Daniel Duncan, MD, Julia A. Elvin, MD, PhD, Vincent A. Miller, MD, Jeffrey S. Ross, MD, Jo-Anne Vergilio, MD, Lawrence R. Zukerberg, MD, Erik A. Williams, MD

Blood (2019) 134 (Supplement_1): 2541.

https://doi.org/10.1182/blood-2019-123729

Published: 2019

Journal Articles

Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency

Eric A. Severson, MD, PhD, MMSc, Ethan S. Sokol, PhD, Russell Madison, PhD, Daniel Duncan, MD, Amanda Hemmerich, MD, Claire Edgerly, MD, Richard Huang, MD, Nicholas Britt, Jo-Anne Vergilio, MD, Julia A Elvin, MD PhD, Prasanth Reddy, MD, Pratheesh Sathyan, MD, Brian Alexander, MD, Jeffrey S. Ross, MD, Siraj M Ali, MD PhD, Shakti H. Ramkissoon, MD PhD

Blood (2019) 134 (Supplement_1): 1437.

https://doi.org/10.1182/blood-2019-131248

Published: 2019

Journal Articles

A Next-Generation Sequencing-Based Karyotyping Algorithm Reveals the Genomic Structure of Acute Myeloid Leukemia

Dean Pavlick, Meagan Montesion, PhD, Nyla A. Heerema, PhD, Eric A Severson, MD PhD MMSc, Timothy Brennan, Garrett M Frampton, Jie He, PhD, John C. Byrd, MD, Ross L. Levine, MD, Amy Burd, PhD, Jo-Anne Vergilio, MD, Lee A Albacker, PhD

Blood (2018) 132 (Supplement 1): 2773.

https://doi.org/10.1182/blood-2018-99-116195

Published: 2018

Journal Articles

Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens

Eric A. Severson, Gregory M. Riedlinger, Caitlin F. Connelly, Jo-Anne Vergilio, Mendel Goldfinger, Shakti Ramkissoon, Garrett M. Frampton, Jeffrey S. Ross, Anthony Fratella-Calabrese, Laurie Gay, Siraj Ali, Vincent Miller, Julia Elvin, Mohammad Hadigol, Kim M. Hirshfield, Lorna Rodriguez-Rodriguez, Shridar Ganesan, Hossein Khiabanian

Blood (2018) 131 (22): 2501–2505.

https://doi.org/10.1182/blood-2018-03-840629

Published: 2018

Includes: Supplemental data

Journal Articles

Unrecognized Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing

Eric A Severson, MD PhD MMSc, Caitlin F Connelly, PhD, Shakti Ramkissoon, MD PhD, Garrett M Frampton, PhD, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Vincent A Miller, MD, Philip J Stephens, PhD, Siraj M Ali, MD PhD, Jeffrey S Ross, MD, Jo-Anne Vergilio, MD

Blood (2017) 130 (Supplement 1): 115.

https://doi.org/10.1182/blood.V130.Suppl_1.115.115

Published: 2017

Journal Articles

Recurrent Copy Number Variants Are Highly Prevalent in Acute Myeloid Leukemia

Katherine Tarlock, MD, Yuting He, James Sun, Rhonda E. Ries, MA, Eric A Severson, MD PhD MMSc, Mark Bailey, MS, Samantha Morley, PhD, Sohail Balasubramanian, Rachel Erlich, PhD, Doron Lipson, PhD, Geoff Otto, PhD, Jo-Anne Vergillo, Jeffrey S Ross, MD, Tariq Mughal, FRCP, Phil Stephens, PhD, Vincent Miller, MD, Soheil Meshinchi, MD PhD, Jie He, PhD

Blood (2017) 130 (Supplement 1): 3800.

https://doi.org/10.1182/blood.V130.Suppl_1.3800.3800

Published: 2017

Journal Articles

Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors

Eric A Severson, MD PhD MMSc, Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Vincent A Miller, MD, Philip J Stephens, PhD, Jeffrey S Ross, MD, Shakti Ramkissoon, MD PhD

Blood (2017) 130 (Supplement 1): 3996.

https://doi.org/10.1182/blood.V130.Suppl_1.3996.3996

Published: 2017

Journal Articles

Comprehensive Genomic Profiling Identifies Genomic Alterations That Define Philadelphia-like B-Acute Lymphoblastic Leukemia

Eric A Severson, MD PhD MMSc, Laurie M Gay, PhD, Sugganth Daniel, MD, Julia A Elvin, MD PhD, James Suh, MD, Michelle Nahas, PhD, Vincent A Miller, MD, Philip J Stephens, PhD, Jeffrey S Ross, MD, Shakti Ramkissoon, MD PhD, Jo-Anne Vergilio, MD

Blood (2017) 130 (Supplement 1): 476.

https://doi.org/10.1182/blood.V130.Suppl_1.476.476

Published: 2017

Journal Articles

Comprehensive Genomic Profiling (CGP) Informs Molecular Diagnosis, Prognosis, and Therapeutic Decision-Making for Patients with Angioimmunoblastic T-Cell Lymphoma (AITL)

Samantha Morley, PhD, Jie He, PhD, Andrew M Intlekofer, MD PhD, Mark Bailey, MS, Michelle Nahas, PhD, Andreas Heilmann, PhD, Yakov Chudnovsky, PhD, David Fabrizio, PhD, Siraj M Ali, MD PhD, Doron Lipson, PhD, Philip J Stephens, PhD, Jeffrey S Ross, MD, Vincent A Miller, MD, Eric A Severson, MD PhD MMSc, Jo-Anne Vergilio, MD, Omar Abdel-Wahab, MD, Rachel Erlich, PhD, Tariq I Mughal, MD FRCP

Blood (2017) 130 (Supplement 1): 5134.

https://doi.org/10.1182/blood.V130.Suppl_1.5134.5134

Published: 2017

Journal Articles

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Jo-Anne Vergilio, MD, Laurie M Gay, PhD, Lei Zhong, PhD, Mark Rosenzweig, PhD, Yakov Chudnovsky, PhD, Jie He, PhD, Michelle Nahas, PhD, Siraj M Ali, MD PhD, Sugganth Daniel, MD, Shakti Ramkissoon, MD PhD, James Suh, MD, Julia A Elvin, MD PhD, Tariq I Mughal, MD FRCP, Philip J Stephens, PhD, Vincent A Miller, MD, Rachel Erlich, PhD, Jeffrey S Ross, MD, Eric A Severson, MD PhD MMSc, Samantha Morley, PhD

Blood (2017) 130 (Supplement 1): 417.

https://doi.org/10.1182/blood.V130.Suppl_1.417.417

Published: 2017

NARROW

Impact of the Updated IPSS-Molecular Prognostic Scoring System for Myelodysplastic Syndrome in 10,283 Real World Samples

Genomic Ancestry in B Cell Lymphoid Malignancies

Acid-Based Decalcification Methods Compromise Genomic Profiling from DNA and RNA

Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations

Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency

A Next-Generation Sequencing-Based Karyotyping Algorithm Reveals the Genomic Structure of Acute Myeloid Leukemia

Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens

Unrecognized Clonal Hematopoiesis of Indeterminate Potential in Solid Tumors: Implications for Interpretation of Molecular Testing

Recurrent Copy Number Variants Are Highly Prevalent in Acute Myeloid Leukemia

Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors

Comprehensive Genomic Profiling Identifies Genomic Alterations That Define Philadelphia-like B-Acute Lymphoblastic Leukemia

Comprehensive Genomic Profiling (CGP) Informs Molecular Diagnosis, Prognosis, and Therapeutic Decision-Making for Patients with Angioimmunoblastic T-Cell Lymphoma (AITL)

Comprehensive Genomic Profiling (CGP) Identifies Novel BCL6 Rearrangements in Diverse Subtypes of Non-Hodgkin Lymphoma (NHL) As Well As Known Rearrangements Not Detected Using Standard of Care (SOC) Assays

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only